NSC45721 Chemical Properties

Melting point:

157 °C

Density 

1.76±0.1 g/cm3(Predicted)

storage temp. 

under inert gas (nitrogen or Argon) at 2-8°C

pka

4.97±0.10(Predicted)

Appearance

White to off-white Solid

Safety Information

HS Code 

2933599590

NSC45721 Usage And Synthesis

Uses

4,6-Dichloro-2-hydroxypyrimidine is a useful building block used in the preparation of diaminopyrimidinone IRAK4 inhibitors. An isomer of 5-Chlorouracil (C423775).

Synthesis

The general procedure for the synthesis of 4,6-dichloro-1H-pyrimidin-2-one from 2,4,6-trichloropyrimidine was carried out as follows: an aqueous 3.8 M sodium hydroxide solution (10 mL, 38.7 mmol) was slowly added to a vigorously stirred solution of 2,4,6-trichloropyrimidine (4.74 g, 25.8 mmol) in tetrahydrofuran (THF, 80 mL). The reaction progression was monitored by liquid chromatography-mass spectrometry (LC-MS) and the product peak (m/z 165, retention time 4.08 min) and residual 2,4,6-trichloropyrimidine (retention time 5.28 min) were observed. After 48 hours of reaction, the reaction mixture was concentrated under reduced pressure and filtered, retaining the filtrate. The resulting precipitate was dissolved in hot water (120 mL) and the pH of the solution was subsequently adjusted to 2 with 3.6 M hydrochloric acid and cooled at 0 °C. The precipitate was collected by filtration, washed with water and dried under reduced pressure to give the first batch of 4,6-dichloro-1H-pyrimidin-2-one (1.17 g, 27% yield) as a white solid. The retained filtrate was concentrated to near dryness and the above purification steps were repeated to afford the second batch of 4,6-dichloro-1H-pyrimidin-2-one (2.03 g, 48% yield) as a white solid. The total yield of the two batches of product was 3.2 g with an overall yield of 75%.

References

[1] Patent: WO2014/188193, 2014, A1. Location in patent: Page/Page column 84-85
[2] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 21, p. 6671 - 6676,6

NSC45721(6297-80-9)Related Product Information

• Alogliptin Impurity 29
• Alogliptin Impurity 7
• (R)-2-((3-methyl-2,4-dioxo-6-(piperidin-3-ylamino)-3,4-Dihydro- pyrimidin-1(2H)-yl)methyl)benzonitrile hydrogen chloride
• Alogliptin Related Compound 18
• 2-[(6-CHLORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)METHYL]BENZONITRILE
• Alogliptin Impurity 34
• Alogliptin Related Compound 32
• Alogliptin Impurity 35
• Alogliptin Related Compound 21
• Alogliptin Impurity B
• (R)-2-((6-(3-((3-(2-cyanobenzyl)-1-Methyl-2,6-dioxo-1,2,3,6-tetrahydropyriMidin-4-yl)aMino)piperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile
• Alogliptin Impurity 16
• Alogliptin Impurity 10
• Alogliptin Related Compound 31
• Alogliptin Related Compound 24
• 2-Cyanobenzyl bromide
• Alogliptin Impurity 11
• Alogliptin Impurity 19